Interní Med. 2009; 11(4): 155-158
Current options of type 2 diabetes pharmacotherapy are broad. Recent knowledge has had a major impact on the therapeutic regimen
and procedure and has proved that glycaemic compensation cannot be obtained without oral antidiabetics. Given the fact that oral
antidiabetics gradually lose efficacy as monotherapy, timely combinations of various types of antidiabetics at lower doses are required.
Other, almost invariably present disorders (arterial hypertension, dyslipidaemia, coagulation disorders) require complex pharmacological
treatment: In a number of patients, it is possible to use combinations of oral antidiabetics, which combine the effects of metphormin
and sulphonylurea or thiazolidindiones, increase patient compliance and thus treatment success.
Published: June 1, 2009 Show citation
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...